药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Enprofylline
Corticotropin
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Corticotropin.
Enprofylline
Abatacept
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Abatacept.
Enprofylline
Nelarabine
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Nelarabine.
Enprofylline
Decitabine
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Decitabine.
Enprofylline
Eculizumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Eculizumab.
Enprofylline
Dexamethasone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dexamethasone.
Enprofylline
Lomustine
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Lomustine.
Enprofylline
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Mitoxantrone.
Enprofylline
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Mitoxantrone.
Enprofylline
Flucytosine
The risk or severity of adverse effects can be increased when Flucytosine is combined with Mitoxantrone.
Enprofylline
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Mitoxantrone.
Enprofylline
Mycophenolic acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Mitoxantrone.
Enprofylline
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Mitoxantrone.
Enprofylline
Azacitidine
The risk or severity of adverse effects can be increased when Azacitidine is combined with Mitoxantrone.
Enprofylline
Mechlorethamine
The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Mitoxantrone.
Enprofylline
Temozolomide
The risk or severity of adverse effects can be increased when Temozolomide is combined with Mitoxantrone.
Enprofylline
Dacarbazine
The risk or severity of adverse effects can be increased when Dacarbazine is combined with Mitoxantrone.
Enprofylline
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Mitoxantrone.
Ethynodiol diacetate
Risdiplam
The serum concentration of Nadolol can be increased when it is combined with Risdiplam.
Ethynodiol diacetate
Oxymetazoline
The risk or severity of hypertension can be increased when Nadolol is combined with Oxymetazoline.